Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.52
Delayed Data
As of Nov 27
 +0.16 / +2.19%
Today’s Change
4.00
Today|||52-Week Range
13.49
-0.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues172.3M149.8M174.7M103.2M
 
 
 
 
 
Cost of Goods Sold10.3M12.6M15.2M16.7M
 
 
 
 
 
Depreciation And Amortization13.1M14.4M4.9M7.4M
 
 
 
 
 
 
Operating ExpensesGross Income148.9M122.8M154.6M79.0M
 
 
 
 
 
General Expenses47.1M78.6M93.0M139.5M
 
 
 
 
 
Research And Development25.5M34.5M33.7M39.3M
 
 
 
 
 
Total Operating Expenses70.4M105.6M113.2M163.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income101.9M44.2M61.5M-60.5M
 
 
 
 
 
Extraordinary Credit0.000.0031.3M22.7M
 
 
 
Extraordinary Charge-30.8M-49.1M-2.6M-67.0M
 
 
 
 
 
Interest Expense On Debt1.4M960.2K1.1M10.6M
 
 
 
 
 
Other Expenses5.7M-5.4M1.4M1.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income78.0M-9.7M93.4M-113.1M
 
 
 
 
 
Income Taxes-37.5M-31.5M-24.6M-17.9M
 
 
 
 
 
Net Income40.4M-41.2M68.8M-95.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.6M41.2M40.5M37.3M
 
 
 
 
 
Shares To Calculate EPS Diluted43.6M41.2M41.8M37.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.99-$1.00$1.70-$2.55
 
 
 
 
 
EPS Diluted$0.93-$1.00$1.64-$2.55